SAN FRANCISCO – In patients infected with hepatitis C virus (HCV) who have decompensated liver disease, a 12-week combination drug regimen with velpatasvir and sofosbuvir (VEL/SOF) with or without...
SAN FRANCISCO – Are policies requiring 6 months of abstinence before liver transplantation in severe alcoholic hepatitis justified, given the potential survival advantage that earlier transplantation...
SAN FRANCISCO – Combination treatment with ledipasvir/sofosbuvir is highly effective for treatment-naive hepatitis C virus genotype 1 patients in routine medical practices, according to findings from...
SAN FRANCISCO – The PALBI liver function score measuring platelet count, albumin, and bilirubin was more effective than Child-Pugh score at predicting survival in hepatocellular carcinoma...
SAN FRANCISCO – Expanding the time between a liver fibrosis patient’s last meal and liver stiffness test may improve the accuracy of the test, according to a Danish study.
In patients referred for...
A triple antiviral combination with direct-acting antiviral (DAA) agents was associated with high rates of sustained virologic response (SVR) across all three hepatitis C virus (HCV) genotypes...
Lusutrombopag, an oral thrombopoietin receptor agonist, was found to reduce the need for platelet transfusion in patients with chronic liver disease with a planned invasive procedure, according to...
Emricasan, a caspase inhibitor, achieves a significant reduction in portal pressure among patients with cirrhosis and severe portal hypertension, according to the abstract for a proof-of-concept...
SAN FRANCISCO – Video capsule endoscopy proved superior to ileocolonoscopy in detecting lesions consistent with Crohn’s disease in patients with known spondyloarthropathies in a study presented at...
SEATTLE – Research in colorectal cancer should focus on part on a handful of high-priority needs for prognostic and predictive biomarkers, according to <a...
